Ad
BPMC - Blueprint Medicines Corporation Stock Trading
About | Blueprint Medicines Corporation (NASDAQ:BPMC)
Not available
Quote | Blueprint Medicines Corporation (NASDAQ:BPMC)
| Last: | $57.75 |
|---|---|
| Change Percent: | -0.04% |
| Open: | $54.3 |
| Close: | $57.75 |
| High: | $58.06 |
| Low: | $53.915 |
| Volume: | 792,520 |
| Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | Blueprint Medicines Corporation (NASDAQ:BPMC)
-
NEJM Evidence Publishes Results from Registrational PIONEER Trial Demonstrating Significant Clinical Benefits of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis PR Newswire -- First and only treatment approved by FDA for indolent SM -- CAM...
-
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis PR Newswire -- For the first time, patients with indolent SM have a medicine that treats the primary disease driver and is proven to provide broad and durable symptom re...
Message Board Posts | Blueprint Medicines Corporation (NASDAQ:BPMC)
| Subject | By | Source | When |
|---|---|---|---|
| Why the drop today...the news release seems positive...anyone | ziggy7796 | investorshub | 08/17/2022 2:40:48 PM |
| BPMC buy 98.69 | stocktrademan | investorshub | 09/12/2021 4:19:19 AM |
| Blueprint Medicines Corp. | TFMG | investorshub | 06/21/2020 6:15:20 PM |
| Avapritinib Today is the date | Frankestin | investorshub | 05/14/2020 10:35:40 AM |
| Sold near EOD @ $59.60. Earnings pre-market tomorrow. | chmcnfunds | investorshub | 07/31/2018 7:58:12 PM |
Blueprint Medicines Corporation Company Name:
BPMC Stock Symbol:
NASDAQ Market:
Blueprint Medicines Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
